McKesson Corporation (MCK)
McKesson (MCK) Laps the Stock Market: Here's Why
In the most recent trading session, McKesson (MCK) closed at $672.99, indicating a +0.74% shift from the previous trading day.
Wall Street Bulls Look Optimistic About McKesson (MCK): Should You Buy?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
McKesson: Immune To Weak Economy And Tariffs; Top Idea In 2025
I maintain a 'Strong Buy' rating on McKesson with a fair value of $723 per share due to its robust oncology network and strong growth prospects. McKesson's minimal exposure to US-Mexico-Canada tariffs and geopolitical tensions ensures stability, making it a reliable investment amid economic uncertainties. The company's GLP-1 and oncology franchises are key growth drivers, with GLP-1 revenue growing 45% year-over-year and oncology patient visits increasing steadily.
McKesson (MCK) Stock Drops Despite Market Gains: Important Facts to Note
McKesson (MCK) closed at $660.86 in the latest trading session, marking a -0.05% move from the prior day.
Trade Tracker: Joe Terranova buys Interactive Brokers and McKesson, sells CVS
Joe Terranova, Senior Managing Director for Virtus Investment Partners, joins CNBC's "Halftime Report" to detail his latest portfolio moves.
McKesson (MCK) and Visa (V) Are 2 Dividend Growth Stocks to Buy For a Lifetime of Passive Income
Investing in dividend growth stocks is a smart, reliable way to build passive income that lasts a lifetime, and it's worth considering if you're eyeing financial freedom.
McKesson (MCK) Increases Yet Falls Behind Market: What Investors Need to Know
In the latest trading session, McKesson (MCK) closed at $663.79, marking a +0.33% move from the previous day.
McKesson (MCK) Advances While Market Declines: Some Information for Investors
McKesson (MCK) closed at $643.69 in the latest trading session, marking a +0.47% move from the prior day.
3 Stocks to Consider With a Possible Recession on the Table
As of early March 2025, investors—and consumers—have once again begun to feel skittish about the possibility of an impending recession. At least two major factors have contributed most recently to this sentiment: first, a dreaded inverted yield curve in the final days of February, and second, the Atlanta Fed's model to predict GDP growth for the first quarter of the year was revised down to -2.8% on March 3, when it had been +4.0% about a month before.
McKesson Keeps Growing, Eyeing Bigger Future
Health care product distributor McKesson Corporation (MCK) reports big earnings gains, eye care acquisition.
McKesson Corporation (MCK) TD Cowen 45th Annual Healthcare Conference Transcript
McKesson Corporation (NYSE:MCK ) TD Cowen 45th Annual Healthcare Conference Call March 4, 2025 9:50 AM ET Company Participants Britt Vitalone – Executive Vice President and Chief Financial Officer Conference Call Participants Unidentified Analyst Good morning. Thanks for joining us for the next session here at the TD Cowen Healthcare Conference and very pleased to have with us McKesson.
Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now?
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
